What we do?
VectraCor uses its patented technology to design and develop medical devices to simplify and reduce costs of diagnostic testing as well as improve patient care. Our latest technology, VectraplexECG can detect ECG changes suggestive of a heart attack and derive a 15-22 lead ECG utilizing only 5-electrodes. We have a entire suite of products that are durable, mobile, and ready to turn an off-the-shelf tablet or laptop into a medical device. Our products are FDA cleared, CE marked, and VectraCor is
Trade Shows 2019
The VectraCor team and CEO Brad Schreck had an excellent time at Medica 2019. If you didn't have time to meet us at our booth and have an inquiry, please feel free to give us a call at 973-904-0444.
Product Manager Michael with Dr. Mixon and Dr. Hardegree!
Our Product Manager Michael with Dr. Kristian Thygesen of Denmark at the European Society of Cardiology Acute Cardiovascular Care Conference.
People in the U.S have heart attacks each year
People die each year from a heart attack
Have a heart attack for the first time each year
Have recurrent heart attacks
Heart Disease Stroke and Research Statisitcs At-a-Glance by American Heart Association